MicroRNAs and exosomes: key players in HIV pathogenesis. Issue 4 (22nd November 2019)

• Record Type: Journal Article
• Authors: Sadri Nahand, J; Bokharaei‐Salim, F; Karimzadeh, M; Moghoofei, M; Karampoor, S; Mirzaei, HR; Tabibzadeh, A; Jafari, A; Ghaderi, A; Asemi, Z; Mirzaei, H; Hamblin, MR
• Is Part Of: HIV medicine. Volume 21:Issue 4(2020)
• Page Start: 246
• Page End: 278
• Publication Date: 2019-11-22
• Subjects: AIDS -- diagnostic biomarkers -- exosomes -- pathogenesis mechanisms -- HIV -- microRNA; HIV infections -- Treatment -- Periodicals; HIV-positive persons -- Periodicals; HIV infections -- Treatment -- Decision making -- Periodicals; 616.9792
• DOI: 10.1111/hiv.12822
• Languages: English
• ISSNs: 1464-2662

Abstract

Abstract : Objectives: HIV infection is well known to cause impairment of the human immune system, and until recently was a leading cause of death. It has been shown that T lymphocytes are the main targets of HIV. The virus inactivates T lymphocytes by interfering with a wide range of cellular and molecular targets, leading to suppression of the immune system. The objective of this review is to investigate to what extent microRNAs (miRNAs) are involved in HIV pathogenesis. Methods: The scientific literature (Pubmed and Google scholar) for the period 1988–2019 was searched. Results: Mounting evidence has revealed that miRNAs are involved in viral replication and immune response, whether by direct targeting of viral transcripts or through indirect modulation of virus‐related host pathways. In addition, exosomes have been found to act as nanoscale carriers involved in HIV pathogenesis. These nanovehicles target their cargos (i.e. DNA, RNA, viral proteins and miRNAs) leading to alteration of the behaviour of recipient cells. Conclusions: miRNAs and exosomes are important players in HIV pathogenesis. Additionally, there are potential diagnostic applications of miRNAs as biomarkers in HIV infection.